LITTLE KNOWN FACTS ABOUT SITUS JUDI MBL77.

Not all people with CLL call for therapy. In spite of all latest innovations, the iwCLL nonetheless recommends watchful observation for individuals with asymptomatic sickness.86 This advice is based on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10